360 related articles for article (PubMed ID: 9748534)
1. A comparative study of in vivo mutation assays: analysis of hprt, lacI, cII/cI and as mutational targets for N-nitroso-N-methylurea and benzo[a]pyrene in Big Blue mice.
Monroe JJ; Kort KL; Miller JE; Marino DR; Skopek TR
Mutat Res; 1998 Oct; 421(1):121-36. PubMed ID: 9748534
[TBL] [Abstract][Full Text] [Related]
2. Mutagenic response of the endogenous hprt gene and lacI transgene in benzo[a]pyrene-treated Big Blue B6C3F1 mice.
Skopek TR; Kort KL; Marino DR; Mittal LV; Umbenhauer DR; Laws GM; Adams SP
Environ Mol Mutagen; 1996; 28(4):376-84. PubMed ID: 8991066
[TBL] [Abstract][Full Text] [Related]
3. Comparison of mutant frequencies at the transgenic lambda LacI and cII/cI loci in control and ENU-treated Big Blue mice.
Zimmer DM; Harbach PR; Mattes WB; Aaron CS
Environ Mol Mutagen; 1999; 33(3):249-56. PubMed ID: 10334627
[TBL] [Abstract][Full Text] [Related]
4. In vivo mutagenicity of ethylene oxide at the hprt locus in T-lymphocytes of B6C3F1 lacI transgenic mice following inhalation exposure.
Walker VE; Sisk SC; Upton PB; Wong BA; Recio L
Mutat Res; 1997 Aug; 392(3):211-22. PubMed ID: 9294020
[TBL] [Abstract][Full Text] [Related]
5. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
Recio L; Saranko CJ; Steen AM
Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
[TBL] [Abstract][Full Text] [Related]
6. Comparison of mutant frequencies and types of mutations induced by thiotepa in the endogenous Hprt gene and transgenic lacI gene of Big Blue rats.
Chen T; Aidoo A; Manjanatha MG; Mittelstaedt RA; Shelton SD; Lyn-Cook LE; Casciano DA; Heflich RH
Mutat Res; 1998 Jul; 403(1-2):199-214. PubMed ID: 9726020
[TBL] [Abstract][Full Text] [Related]
7. Frequency and spectrum of ethylnitrosourea-induced mutation at the hprt and lacI loci in splenic lymphocytes of exposed lacI transgenic mice.
Walker VE; Gorelick NJ; Andrews JL; Craft TR; deBoer JG; Glickman BW; Skopek TR
Cancer Res; 1996 Oct; 56(20):4654-61. PubMed ID: 8840980
[TBL] [Abstract][Full Text] [Related]
8. Relative sensitivity of the endogenous hprt gene and lacI transgene in ENU-treated Big Blue B6C3F1 mice.
Skopek TR; Kort KL; Marino DR
Environ Mol Mutagen; 1995; 26(1):9-15. PubMed ID: 7641713
[TBL] [Abstract][Full Text] [Related]
9. Mutant frequencies and mutation spectra of dimethylnitrosamine (DMN) at the lacI and cII loci in the livers of Big Blue transgenic mice.
Shane BS; Smith-Dunn DL; de Boer JG; Glickman BW; Cunningham ML
Mutat Res; 2000 Sep; 452(2):197-210. PubMed ID: 11024479
[TBL] [Abstract][Full Text] [Related]
10. Detection of cyclophosphamide-induced mutations at the Hprt but not the lacI locus in splenic lymphocytes of exposed mice.
Walker VE; Andrews JL; Upton PB; Skopek TR; deBoer JG; Walker DM; Shi X; Sussman HE; Gorelick NJ
Environ Mol Mutagen; 1999; 34(2-3):167-81. PubMed ID: 10529741
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen induces G:C-->T:A mutations in the cII gene in the liver of lambda/lacI transgenic rats but not at 5'-CpG-3' dinucleotide sequences as found in the lacI transgene.
Davies R; Gant TW; Smith LL; Styles JA
Carcinogenesis; 1999 Jul; 20(7):1351-6. PubMed ID: 10383911
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous and ENU-induced mutation spectra at the cII locus in Big Blue Rat2 embryonic fibroblasts.
Watson DE; Cunningham ML; Tindall KR
Mutagenesis; 1998 Sep; 13(5):487-97. PubMed ID: 9800194
[TBL] [Abstract][Full Text] [Related]
13. Comparison of in vivo mutagenesis in the endogenous Hprt gene and the lacI transgene of Big Blue(R) rats treated with 7, 12-dimethylbenz[a]anthracene.
Manjanatha MG; Shelton SD; Aidoo A; Lyn-Cook LE; Casciano DA
Mutat Res; 1998 Jun; 401(1-2):165-78. PubMed ID: 9639698
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the in vivo mutagenicity of ethylene oxide in the tissues of B6C3F1 lacI transgenic mice following inhalation exposure.
Sisk SC; Pluta LJ; Meyer KG; Wong BC; Recio L
Mutat Res; 1997 Jul; 391(3):153-64. PubMed ID: 9268040
[TBL] [Abstract][Full Text] [Related]
15. Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice.
Kohler SW; Provost GS; Fieck A; Kretz PL; Bullock WO; Sorge JA; Putman DL; Short JM
Proc Natl Acad Sci U S A; 1991 Sep; 88(18):7958-62. PubMed ID: 1832771
[TBL] [Abstract][Full Text] [Related]
16. Mutant frequency of lacI in transgenic mice following benzo[a]pyrene treatment and partial hepatectomy.
Shane BS; Lockhart AM; Winston GW; Tindall KR
Mutat Res; 1997 Jun; 377(1):1-11. PubMed ID: 9219573
[TBL] [Abstract][Full Text] [Related]
17. Gene- and tissue-specificity of mutation in Big Blue rats treated with the hepatocarcinogen N-hydroxy-2-acetylaminofluorene.
Chen T; Mittelstaedt RA; Shelton SD; Dass SB; Manjanatha MG; Casciano DA; Heflich RH
Environ Mol Mutagen; 2001; 37(3):203-14. PubMed ID: 11317338
[TBL] [Abstract][Full Text] [Related]
18. The genetic analysis of lacI mutations in sectored plaques from Big Blue transgenic mice.
Stuart GR; Gorelick NJ; Andrews JL; de Boer JG; Glickman BW
Environ Mol Mutagen; 1996; 28(4):385-92. PubMed ID: 8991067
[TBL] [Abstract][Full Text] [Related]
19. Comparison of hprt and lacI mutant frequency with DNA adduct formation in N-hydroxy-2-acetylaminofluorene-treated Big Blue rats.
Chen T; Mittelstaedt RA; Aidoo A; Hamilton LP; Beland FA; Casciano DA; Heflich RH
Environ Mol Mutagen; 2001; 37(3):195-202. PubMed ID: 11317337
[TBL] [Abstract][Full Text] [Related]
20. Species-specific differences in hepatic mutant frequency and mutational spectrum among lambda/lacI transgenic rats and mice following exposure to aflatoxin B1.
Dycaico MJ; Stuart GR; Tobal GM; de Boer JG; Glickman BW; Provost GS
Carcinogenesis; 1996 Nov; 17(11):2347-56. PubMed ID: 8968048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
